106 related articles for article (PubMed ID: 69898)
1. Scalp tingling in patients on labetalol.
Hua AS; Thomas GW; Kincaid-Smith P
Lancet; 1977 Aug; 2(8032):295. PubMed ID: 69898
[No Abstract] [Full Text] [Related]
2. Scalp tingling and difficulty in micturition in patients on labetalol.
Bailey RR
Lancet; 1977 Oct; 2(8040):720-1. PubMed ID: 71532
[No Abstract] [Full Text] [Related]
3. Circumoral paraesthesiae and labetalol.
Gabriel R
Br Med J; 1978 Mar; 1(6112):580. PubMed ID: 630239
[No Abstract] [Full Text] [Related]
4. A comparison of scalp tingling, thirst and polyuria in patients on labetalol and metoprolol.
Coulter DM
N Z Med J; 1979 Nov; 90(647):397. PubMed ID: 293566
[No Abstract] [Full Text] [Related]
5. Labetalol in hypertension.
Lancet; 1977 May; 1(8022):1147-8. PubMed ID: 68239
[No Abstract] [Full Text] [Related]
6. Labetalol in essential hypertension.
Breckenridge A; Orme M; Serlin MJ; Maciver M
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):37S-39S. PubMed ID: 6124264
[TBL] [Abstract][Full Text] [Related]
7. [Labetalol in ambulatory therapy of hypertension].
Zilcher H; Weber H; Glogar D
Wien Med Wochenschr Suppl; 1981; 69():23-4. PubMed ID: 6952656
[No Abstract] [Full Text] [Related]
8. Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.
Steiner JA; Cooper R; Gear JS; Ledingham JG
Br J Clin Pharmacol; 1979 Apr; 7(4):401-3. PubMed ID: 375960
[No Abstract] [Full Text] [Related]
9. Left ventricular failure with labetalol.
Frais MA; Bayley TJ
Postgrad Med J; 1979 Sep; 55(646):567-8. PubMed ID: 514938
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous reaction to labetalol.
Branford WA; Hunter JA; Muir AL
Practitioner; 1978 Nov; 221(1325):765-7. PubMed ID: 154093
[No Abstract] [Full Text] [Related]
11. Hemiparesis after single minibolus of labetalol for hypertensive encephalopathy.
Solomons R
Br Med J; 1979 Sep; 2(6191):672. PubMed ID: 115540
[No Abstract] [Full Text] [Related]
12. [Clinical trial of labetalol (Tranedate) in general practice].
Mathisen R; Sveen K
Tidsskr Nor Laegeforen; 1983 Feb; 103(5):541-3. PubMed ID: 6223408
[No Abstract] [Full Text] [Related]
13. Letter: Intravenous labetalol in severe hypertension.
Rosei EA; Trust PM; Brown JJ; Lever AF; Robertson JI
Lancet; 1975 Nov; 2(7944):1093-4. PubMed ID: 53581
[No Abstract] [Full Text] [Related]
14. Side-effects with long-term labetalol: an open study of 251 patients in a single centre.
Tcherdakoff P
Pharmatherapeutica; 1983; 3(5):342-8. PubMed ID: 6844370
[TBL] [Abstract][Full Text] [Related]
15. Labetalol and alprenolol. A comparative investigation of antihypertensive effect.
Kofod P; Kjaer K; Vejlø S; Hvidt S
Postgrad Med J; 1980; 56 Suppl 2():69-74. PubMed ID: 7001423
[No Abstract] [Full Text] [Related]
16. Hypertensive response to labetalol in phaeochromocytoma.
Briggs RS; Birtwell AJ; Pohl JE
Lancet; 1978 May; 1(8072):1045-6. PubMed ID: 76965
[No Abstract] [Full Text] [Related]
17. Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children.
Thomas CA; Moffett BS; Wagner JL; Mott AR; Feig DI
Pediatr Crit Care Med; 2011 Jan; 12(1):28-32. PubMed ID: 20495503
[TBL] [Abstract][Full Text] [Related]
18. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycaemia secondary to labetalol infusion.
Immanni S; Khan EI; Staunton M
J Coll Physicians Surg Pak; 2011 May; 21(5):297-8. PubMed ID: 21575539
[TBL] [Abstract][Full Text] [Related]
20. Intravenous labetalol in the emergency treatment of hypertension.
Vidt DG
J Clin Hypertens; 1985 Jun; 1(2):179-86. PubMed ID: 3915322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
